Kim Waggie
ZymoGenetics
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kim Waggie.
Nature Immunology | 2004
Stacey R. Dillon; Cindy A. Sprecher; Angela K. Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R. Presnell; Harald S. Haugen; Mark Maurer; Brandon Harder; Janet V. Johnston; Susan Bort; Sherri Mudri; Joseph L. Kuijper; Tom Bukowski; Pamela Shea; Dennis L. Dong; Maria M. Dasovich; Francis J. Grant; Luann Lockwood; Steven D. Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet M. Kramer; Rolf E. Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A. Gross
T cell–derived cytokines are important in the development of an effective immune response, but when dysregulated they can promote disease. Here we identify a four-helix bundle cytokine we have called interleukin 31 (IL-31), which is preferentially produced by T helper type 2 cells. IL-31 signals through a receptor composed of IL-31 receptor A and oncostatin M receptor. Expression of IL-31 receptor A and oncostatin M receptor mRNA was induced in activated monocytes, whereas epithelial cells expressed both mRNAs constitutively. Transgenic mice overexpressing IL-31 developed severe pruritis, alopecia and skin lesions. Furthermore, IL-31 receptor expression was increased in diseased tissues derived from an animal model of airway hypersensitivity. These data indicate that IL-31 may be involved in promoting the dermatitis and epithelial responses that characterize allergic and non-allergic diseases.
Immunity | 2001
Jane A. Gross; Stacey R. Dillon; Sherri Mudri; Janet V. Johnston; Alisa Littau; Richard Roque; Mark W. Rixon; Ole Schou; Kevin P. Foley; Harald S. Haugen; Susan McMillen; Kim Waggie; Randy W Schreckhise; Kim Shoemaker; Tuyen Vu; Margaret D. Moore; Angelika Grossman; Chris Clegg
BLyS and APRIL have similar but distinct biological roles, mediated through two known TNF receptor family members, TACI and BCMA. We show that mice treated with TACI-Ig and TACI-Ig transgenic mice have fewer transitional T2 and mature B cells and reduced levels of circulating immunoglobulin. TACI-Ig treatment inhibits both the production of collagen-specific Abs and the progression of disease in a mouse model of rheumatoid arthritis. In BLyS-deficient mice, B cell development is blocked at the transitional T1 stage such that virtually no mature B cells are present, while B-1 cell numbers are relatively normal. These findings further elucidate the roles of BLyS and APRIL in modulating B cell development and suggest that BLyS is required for the development of most but not all mature B cell populations found in the periphery.
Cell | 2001
Hal Blumberg; Darrell Conklin; Wenfeng Xu; Angelika Grossmann; Ty Brender; Susan Carollo; Maribeth Eagan; Don Foster; Betty A. Haldeman; Angie Hammond; Harald S. Haugen; Laura J. Jelinek; James D. Kelly; Karen Madden; Mark Maurer; Julia Parrish-Novak; Donna E. Prunkard; Shannon Sexson; Cindy A. Sprecher; Kim Waggie; James W. West; Theodore E. Whitmore; Lena Yao; Melanie K. Kuechle; Beverly A. Dale; Yasmin A. Chandrasekher
A structural, profile-based algorithm was used to identify interleukin 20 (IL-20), a novel IL-10 homolog. Chromosomal localization of IL-20 led to the discovery of an IL-10 family cytokine cluster. Overexpression of IL-20 in transgenic (TG) mice causes neonatal lethality with skin abnormalities including aberrant epidermal differentiation. Recombinant IL-20 protein stimulates a signal transduction pathway through STAT3 in a keratinocyte cell line, demonstrating a direct action of this ligand. An IL-20 receptor was identified as a heterodimer of two orphan class II cytokine receptor subunits. Both receptor subunits are expressed in skin and are dramatically upregulated in psoriatic skin. Taken together, these results demonstrate a role in epidermal function and psoriasis for IL-20, a novel cytokine identified solely by bioinformatics analysis.
Journal of Molecular Medicine | 2009
Kerstin Wolk; Harald S. Haugen; Wenfeng Xu; Ellen Witte; Kim Waggie; Monica Anderson; Elmar vom Baur; Katrin Witte; Katarzyna Warszawska; Sandra Philipp; Caroline Johnson-Leger; Hans-Dieter Volk; Wolfram Sterry; Robert Sabat
Psoriasis is a common chronic skin disease with a largely unknown pathogenesis. We demonstrate here that transgenic over-expression of interleukin (IL)-22 in mice resulted in neonatal mortality and psoriasis-like skin alterations including acanthosis and hypogranularity. This cutaneous phenotype may be caused by the direct influence of IL-22 on keratinocytes, since this cytokine did not affect skin fibroblasts, endothelial cells, melanocytes, or adipocytes. The comparison of cytokines with hypothesized roles in psoriasis pathogenesis determined that neither interferon (IFN)-γ nor IL-17, but only IL-22 and, with lower potency, IL-20 caused psoriasis-like morphological changes in a three-dimensional human epidermis model. These changes were associated with inhibited keratinocyte terminal differentiation and with STAT3 upregulation. The IL-22 effect on differentiation-regulating genes was STAT3-dependent. In contrast to IL-22 and IL-20, IFN-γ and IL-17 strongly induced T-cell and neutrophilic granulocyte-attracting chemokines, respectively. Tumor necrosis factor-α potently induced diverse chemokines and additionally enhanced the expression of IL-22 receptor pathway elements and amplified some IL-22 effects. This study suggests that different cytokines are players in the psoriasis pathogenesis although only the IL-10 family members IL-22 and IL-20 directly cause the characteristic epidermal alterations.
Clinical & Experimental Allergy | 2008
Janine Bilsborough; Eric M. Chadwick; Sherri Mudri; X. Ye; William R. Henderson; Kim Waggie; L. Hebb; J. Shin; Mark W. Rixon; Jane A. Gross; Stacey R. Dillon
Background Increased levels of serum IgE are associated with greater asthma prevalence and disease severity. IgE depletion using an anti‐IgE monoclonal antibody has met with success in the treatment of moderate‐to‐severe and severe persistent allergic asthma.
American Journal of Physiology-gastrointestinal and Liver Physiology | 2001
Andrew Burich; Robert M. Hershberg; Kim Waggie; Weiping Zeng; Thea Brabb; Gina M. Westrich; Joanne L. Viney; Lillian Maggio-Price
American Journal of Pathology | 2002
Lillian Maggio-Price; Donna Shows; Kim Waggie; Andrew Burich; Weiping Zeng; Sabine S. Escobar; Phil Morrissey; Joanne L. Viney
Gastroenterology | 2009
Katherine E. Lewis; Janine Bilsborough; Mark Maurer; Kristen Bontadelli; Kim Waggie; Cecile M. Krejsa; Stacey R. Dillon
Journal of Immunotherapy | 2004
Steven D. Hughes; Lay Chin; Kim Waggie; Pallavur V. Sivakumar; Cindy Yen; Chris Clegg
Gastroenterology | 2001
Lillian Maggio-Price; Donna Shows; Kim Waggie; Andrew Burich; Weiping Zeng; Phil Morrissey; Joanne L. Viney